The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 14, 2020
Filed:
Apr. 29, 2016
Applicant:
Pharnext, Issy les Moulineaux, FR;
Inventors:
Daniel Cohen, Saint Cloud, FR;
Ilya Chumakov, Vaux le Penil, FR;
Serguei Nabirochkin, Catenay Malabry, FR;
Rodolphe Hajj, Saint Germain en Laye, FR;
Assignee:
PHARNEXT, Issy les Moulineaux, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61K 31/55 (2006.01); A61K 31/122 (2006.01); A61K 31/216 (2006.01); A61K 31/53 (2006.01); A61K 31/4164 (2006.01); A61K 31/495 (2006.01); A61K 31/445 (2006.01); A61K 31/16 (2006.01); A61K 31/519 (2006.01); A61K 31/7004 (2006.01); A61K 31/197 (2006.01); A61K 31/138 (2006.01); A61K 31/137 (2006.01); A61K 31/44 (2006.01); A61K 31/422 (2006.01); A61K 31/155 (2006.01); A61K 31/42 (2006.01); A61K 31/135 (2006.01); A61K 31/196 (2006.01); A61K 31/24 (2006.01); A61K 31/4745 (2006.01); A61K 31/50 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/122 (2013.01); A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/138 (2013.01); A61K 31/155 (2013.01); A61K 31/16 (2013.01); A61K 31/196 (2013.01); A61K 31/197 (2013.01); A61K 31/216 (2013.01); A61K 31/24 (2013.01); A61K 31/4164 (2013.01); A61K 31/42 (2013.01); A61K 31/422 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/445 (2013.01); A61K 31/4745 (2013.01); A61K 31/495 (2013.01); A61K 31/50 (2013.01); A61K 31/53 (2013.01); A61K 31/55 (2013.01); A61K 31/7004 (2013.01); A61K 45/06 (2013.01);
Abstract
The present invention relates to compositions and methods for controlling glycaemia in a mammalian in need thereof. The present invention relates to compositions and methods for the treatment of diabetes disease and related disorders. More specifically, the present invention relates to novel therapies or combinatorial therapies of diabetes and related disorders, based on compositions controlling the blood glucose level.